Surrey, UK -- (MARKET WIRE) -- November 16, 2006 --
Sinclair Pharma plc presenting at
Piper Jaffray Annual Global Healthcare Conference
16 November 2006, Godalming, UK - Sinclair Pharma plc (AIM: SPH.L), the
international specialty pharmaceutical company today announces that its Chief
Executive Officer, Dr Michael Flynn, and Chief Financial Officer Jerry Randall,
will be presenting at the Piper Jaffray Health Care Conference at the Pierre
Hotel, New York, on Wednesday 29th November at 3.30pm.
A live webcast of Sinclair's presentation will be available at
http://www.piperjaffray.com/hcwebcast. The presentation and further company
information will also be available at
www.sinclairpharma.com.
Sinclair Pharma plc
Sinclair Pharma plc is an international specialty pharmaceutical company. It
has a growing sales and marketing operation that is already present in France,
Italy, the UK, Spain and Portugal, and a complementary marketing partner network
that spans 60 countries.
Sinclair has proven expertise in acquiring or developing commercially attractive
and undervalued products, registering these products and bringing them to market
within a short time frame. The company focuses on niche therapeutic areas and
its current portfolio includes products for dermatological conditions and oral
health.
Enquiries:
Sinclair Pharma plc Tel: +44 1483 410 600
Zoe McDougall +44 7973 792 520
John Barrington-Carver Tel: +44 7831 655 630
Sinclair US
Mike Killeen Tel +1 972 478 4380
This information is provided by RNS
The company news service from the London Stock Exchange